DAWN2 study results - a sample of country reports

The DAWN2TM study involved three separate quantitative surveys: one for people with diabetes, one for family members and one for healthcare professionals totalling 15,438 participants from 17 countries. Data was systematically coded in cooperation with collaborators in each of the DAWN2 countries. In an effort to review key insights and future objectives from a set of very diverse regions, abbreviated reports from the following nine participating DAWN2 study countries are provided: Algeria, Canada, China, Denmark, India, Italy, Mexico, Russia, and Spain.  

DAWN2 study, diabetes